Arbitrage Radar

Catalyst Intel: Governor Newsom has publicly stated his opposition to the "billionaire tax," which is a significant negative catalyst. A governor's opposition can heavily influence public opinion and mobilize resources against a ballot initiative. Additionally, the news indicates that tech giants are spending heavily to influence California politics, suggesting strong financial opposition is likely for such a tax.

Legal Reasoning: Market A resolves to 'Yes' if a specific ballot initiative is certified by June 25, 2026, for the November 3, 2026 California election. Market B resolves to 'Yes' if such an initiative 'passes' voter approval. For Market B to resolve to 'Yes', the initiative must first be certified and appear on the ballot. Market A imposes a stricter, earlier deadline (June 25, 2026) for this certification compared to the implicit requirements for Market B. If an initiative is certified after June 25, 2026, but still makes it onto the November 3, 2026 ballot and passes voter approval, Market B would resolve to 'Yes' while Market A would resolve to 'No'. This scenario indicates that Market A's conditions are stricter or have an earlier deadline for a prerequisite event compared to Market B's resolution condition, fitting the definition of A_SUBSET_OF_B, despite the parenthetical clause in the definition not being strictly met due to the possibility of certification by June 25 but failure to pass voter approval.

Catalyst Intel: The news provides strong and specific indications that multiple companies are actively planning or are expected to IPO before 2027. Kailera Therapeutics has definitively filed for a US IPO. Anthropic is reported to be coming as early as October (implying 2024) or late 2026. OpenAI is eyeing 2026 or 2027, and there is significant 'buzz' around a SpaceX IPO. This collective information, especially the concrete filing and specific timelines for major players, significantly increases the probability of several IPOs occurring within the specified timeframe, indicating an 'AI IPO Gold Rush' is underway.

Legal Reasoning: Both markets predict whether Anthropic will complete an Initial Public Offering (IPO) by the end of 2026. Market A explicitly states 'completes an Initial Public Offering (IPO)', while Market B states 'Anthropic confirms an IPO'. In the context of prediction markets, 'confirms an IPO' is understood to mean the IPO has completed or is definitively occurring. Therefore, if the IPO 'completes', Anthropic will 'confirm' it, and vice versa. The deadlines are identical ('by December 31, 2026, 11:59 PM ET' is equivalent to 'before Jan 1, 2027'). Market A's resolution sources ('official company announcements or credible news sources') include Anthropic's confirmation. There are no conflicting conditions, definitions, or tie-breakers.

Catalyst Intel: Kailera Therapeutics has filed for a U.S. IPO, indicating an imminent public offering well before 2027. Anthropic is reportedly planning an IPO as early as October, with talks already underway with major banks, strongly suggesting an IPO before 2027. OpenAI has strong signals for a 2026 IPO, supported by SoftBank's $40B loan maturing in March 2027, providing flexibility for a listing within that timeframe. Visma, while delayed, is still expected to IPO next year, placing it before 2027. These events collectively represent massive catalysts, confirming that multiple significant companies are on track to IPO before 2027.

Legal Reasoning: Both markets concern an IPO by Databricks with identical deadlines (Market A: 'by December 31, 2026, 11:59 PM ET'; Market B: 'before Jan 1, 2027'). Market B's confirmation source ('Databricks confirms an IPO') is a subset of Market A's ('official company announcements or credible news sources'). In practice, if an IPO occurs and is confirmed by official company announcements or credible news sources, Databricks itself would almost certainly have confirmed it. The 'No' conditions in Market A are standard implicit understandings for IPO markets and do not create a conflict or a scenario where one market resolves 'Yes' and the other 'No' for the same event. Therefore, the conditions and timeframes are virtually identical.

Catalyst Intel: No news was provided to evaluate for a catalyst. Therefore, no catalyst can be identified for the market 'Will GOP Nominee be Ken Paxton AND General Election Winner be Republican for Jan 2027?'.

Legal Reasoning: For Market A to resolve to 'Paxton beats Talarico', Ken Paxton must be the Republican nominee and win the 2026 Texas U.S. Senate election. This outcome directly matches the conditions for Market B to resolve 'Yes' (GOP Nominee: Ken Paxton, General Election Winner: Republican). The timeframe for a 2026 election, including potential run-offs, would typically see the winner determined and called by news sources (Market A's primary resolution method) well before Market B's 'before Jan 2027' deadline. Assuming standard political definitions and avoiding pedantic edge cases, the conditions and timeframes are virtually identical.

Catalyst Intel: Multiple news snippets confirm that several high-profile companies, including OpenAI, Anthropic, and SpaceX, are actively pursuing or are expected to IPO before 2027. Kailera Therapeutics has already filed for a US IPO. This collective information strongly indicates that the "AI IPO Gold Rush" is indeed underway and will result in multiple companies going public within the market's specified timeframe, providing strong candidates for the "who" aspect of the market.

Legal Reasoning: Both markets resolve to "Yes" if Brex completes an Initial Public Offering (IPO) by December 31, 2026. The deadline "before Jan 1, 2027" in Market B is identical to "by December 31, 2026, 11:59 PM ET" in Market A. In the context of an IPO, "confirms an IPO" (Market B) is practically equivalent to "completes an IPO" (Market A), as a company's IPO cannot be completed without official confirmation (e.g., through filings or announcements). The resolution sources are also practically aligned, as official company confirmation would constitute credible reporting.

Catalyst Intel: The news indicates significant pressure on Prime Minister Netanyahu. A tense call with US Vice President JD Vance reveals direct criticism of Netanyahu's 'overconfidence' and misrepresentation of the Iran war to the US, signaling a potential strain in crucial US-Israel relations. Additionally, the release of 'The Bibi Files' by Tucker Carlson's network suggests a potentially damaging exposé that could further erode public and political support. These events, particularly the high-level international criticism and a potentially critical documentary, constitute a massive catalyst that could impact his tenure.

Legal Reasoning: Both markets resolve to "Yes" if Benjamin Netanyahu announces resignation, steps down, or is removed from the position of Prime Minister of Israel. The deadline for both markets is identical: Market A specifies "by December 31, 2026, 11:59 PM ET", while Market B states "before Jan 1, 2027", which covers the exact same period. The conditions and timeframes are virtually identical, meaning if one market resolves to "Yes", the other will as well, and vice-versa. There are no stricter conditions, earlier deadlines, or conflicting rules that would lead to a different resolution.

Catalyst Intel: The news provides multiple strong indicators that several prominent companies are moving towards an IPO before 2027. OpenAI is linked to a 2026 IPO due to a SoftBank loan. Anthropic is repeatedly mentioned with timelines such as 'as early as October' (this year), 'Q4 IPO', and 'late 2026'. SpaceX is also described as 'finally going public' with its 'listing date nears'. Most definitively, Kailera Therapeutics has already filed for a US IPO. These are concrete steps and strong signals that these companies are actively pursuing public listings within the specified timeframe, significantly increasing the probability of their IPOs before 2027.

Legal Reasoning: Market A resolves to 'Yes' if Celonis completes an Initial Public Offering (IPO) by December 31, 2026, 11:59 PM ET, as confirmed by official company announcements or credible news sources. Market B resolves to 'Yes' if Celonis confirms an IPO before January 1, 2027. The term 'confirms an IPO' in Market B, in the context of 'Who will IPO?', is interpreted as the confirmation of the *completion* of the IPO, rather than merely an announcement of intent. Both deadlines are identical (by December 31, 2026). The confirmation sources are also highly similar, with Market B's 'Celonis confirms an IPO' falling under Market A's 'official company announcements or credible news sources'. Therefore, the conditions and timeframes are virtually identical for practical resolution.

Catalyst Intel: Multiple news snippets indicate a strong likelihood of several high-profile companies IPOing before 2027. Kailera Therapeutics has already filed for a US IPO. Anthropic is reported to be coming as early as October (this year). Visma is delaying its IPO to next year (2025). SK hynix confidentially filed for a US IPO in April 2025. OpenAI is strongly signaled for a 2026 or early 2027 IPO, with SoftBank's $40B loan maturing in March 2027. SpaceX is also mentioned as 'coming soon'. This collective information points to a significant number of IPOs occurring within the specified timeframe.

Legal Reasoning: Both markets refer to an IPO by OpenAI. Market A's deadline is "by December 31, 2026, 11:59 PM ET", which is functionally identical to Market B's "before Jan 1, 2027". Market A's definition of an IPO ("first sale of stock...to the public on any recognized stock exchange") is a standard understanding of an IPO, and Market B's "confirms an IPO" would rely on the same event. Market A's negative conditions (merger, acquisition, cessation of existence) are implicit in Market B as well; if OpenAI doesn't exist, it can't IPO. There are no material differences in conditions or timeframes that would lead to divergent resolutions.

Catalyst Intel: Multiple companies, including Kailera Therapeutics, Anthropic, OpenAI, Visma AS, and SpaceX, show strong indications or have already filed for an IPO before 2027. Kailera Therapeutics has filed for a US IPO. Anthropic is reported to be coming as early as October. OpenAI is hinted for a 2026 or early 2027 IPO. Visma AS is delaying its IPO to next year (2025). SpaceX is also mentioned as 'coming soon'. These events collectively represent a significant increase in the likelihood of companies IPOing before 2027.

Legal Reasoning: Both markets resolve to 'Yes' if Deel completes an Initial Public Offering (IPO) by December 31, 2026. Market A specifies 'by December 31, 2026, 11:59 PM ET', while Market B states 'before Jan 1, 2027', which is the exact same timeframe. The resolution sources and definitions of an IPO are also consistent across both markets. If an IPO occurs, both will resolve 'Yes'; if not, both will resolve 'No'.

Catalyst Intel: The news contains multiple strong indicators of high-profile companies planning or actively pursuing IPOs before 2027. Anthropic is repeatedly mentioned with timelines as early as 'October' or 'Q4 IPO' (this year) and 'late 2026'. Kailera Therapeutics has already filed for a U.S. IPO. OpenAI is linked to a '2026 OpenAI IPO' or '2026 or 2027' timeline, and SpaceX is consistently reported as 'finally going public' with its listing date nearing. These concrete developments significantly increase the probability of multiple major IPOs occurring within the specified timeframe.

Legal Reasoning: Both markets resolve to 'Yes' if Ramp completes an IPO by December 31, 2026. Market A specifies 'completes an Initial Public Offering (IPO) by December 31, 2026, 11:59 PM ET', while Market B states 'confirms an IPO before Jan 1, 2027'. These timeframes are identical. The terms 'completes an IPO' and 'confirms an IPO' are considered equivalent in this context, referring to the successful public offering of stock. Market A's explicit 'No' conditions (merger, acquisition, ceases to exist) are implicitly covered in Market B, as an IPO by Ramp would not occur under those circumstances.

Catalyst Intel: The news indicates significant and sustained pressure to weaken or eliminate the filibuster, primarily driven by former President Trump and Senator JD Vance. The filibuster is directly impeding critical legislation like the SAVE America Act and contributing to the DHS shutdown, leading to calls for 'nuking' or 'carve-outs' of the rule. This high-stakes legislative context and prominent political advocacy constitute a massive catalyst for the filibuster being weakened before 2027.

Legal Reasoning: Market A requires a specific event: a cloture motion passing with fewer than three-fifths of Senators on a legislative matter. For such a motion to pass, the filibuster threshold must first have been lowered for the legislative process. Market B is broader, resolving to "Yes" if the filibuster threshold is lowered in any capacity (e.g., for legislative matters, confirmations, or both) and does not require an instance of a cloture motion passing. If Market A resolves "Yes," it inherently means the filibuster threshold was lowered, making Market B also resolve "Yes." However, Market B could resolve "Yes" without Market A resolving "Yes" if: 1) the threshold is lowered only for confirmations (which Market A explicitly excludes), or 2) the threshold is lowered for legislative matters, but no actual cloture motion passes under the new threshold before the deadline. Therefore, Market A's conditions are stricter than Market B's.

Catalyst Intel: Multiple news snippets indicate OpenAI is actively preparing for an IPO. Specifically, 'OpenAI Cleans House Ahead of IPO' suggests strategic streamlining for a public offering. Furthermore, the 'OpenAI ads pilot tops $100 million in annualized revenue in under 2 months' demonstrates significant, rapid financial growth in a high-margin business, which is highly attractive to potential IPO investors and a key step in 'sprucing up their financials ahead of mega-IPOs'. These actions and financial successes are strong indicators that an IPO is on the horizon and likely to occur sooner rather than later.

Legal Reasoning: Both markets are tracking the same event: OpenAI completing an Initial Public Offering (IPO) before January 1, 2027. Market A's definition of an IPO and resolution sources align perfectly with the natural interpretation of Market B's conditions. The specific clause in Market A regarding acquisition by an already public company explicitly states a scenario that would implicitly lead to a 'No' resolution in Market B, as OpenAI itself would not have performed an IPO. Therefore, the conditions and outcomes are virtually identical.

Catalyst Intel: Multiple prominent companies, including OpenAI, Anthropic, and SpaceX, are actively planning or discussing IPOs with timelines explicitly mentioning 2026, 2027, or 'this year' (for Anthropic). Kailera Therapeutics has already filed for a U.S. IPO. This indicates a strong likelihood of several significant IPOs occurring before 2027.

Legal Reasoning: Both markets resolve to "Yes" if Anysphere (Cursor) completes an IPO by December 31, 2026. Market A's deadline of "December 31, 2026, 11:59 PM ET" is equivalent to Market B's "before Jan 1, 2027". While Market A explicitly mentions negative resolution for mergers/acquisitions/cessation, it is a standard assumption that an IPO for the named entity would not occur if it were acquired or ceased to exist, meaning Market B would also implicitly resolve "No" in such scenarios. The conditions and timeframes are virtually identical.

Catalyst Intel: Multiple major companies, including Anthropic, OpenAI, and SpaceX, are reported to be actively pursuing or nearing IPOs in 2026 or even earlier (Anthropic as early as October/Q4). Kailera Therapeutics has already filed for a US IPO. This collective news strongly indicates that several significant IPOs are highly probable before 2027, representing a massive catalyst for the market.

Legal Reasoning: Both markets refer to an IPO by 'Stripe' with identical deadlines ('by December 31, 2026, 11:59 PM ET' is equivalent to 'before Jan 1, 2027'). The condition of 'completes an Initial Public Offering' in Market A and 'confirms an IPO' in Market B are functionally equivalent for market resolution, as an IPO confirmation typically signifies its completion in the context of public trading. Market A's specific 'No' conditions for mergers, acquisitions, or cessation of existence align with implicit 'No' outcomes for Market B, as such events would preclude Stripe from confirming an IPO.

Catalyst Intel: The news contains multiple strong indicators for several high-profile companies planning or nearing IPOs in 2026, which is before 2027. Anthropic is reported to be coming as early as October or late 2026, OpenAI is eyeing 2026, and SpaceX is described as 'finally going public' with its listing date nearing. Additionally, Kailera Therapeutics has already filed for a US IPO. This collective information constitutes a massive catalyst, significantly increasing the likelihood of multiple companies IPOing before 2027.

Legal Reasoning: Both markets refer to an IPO by Vanta. Market A's deadline is "by December 31, 2026, 11:59 PM ET", which is identical to Market B's "before Jan 1, 2027". The resolution sources and conditions for an IPO confirmation are also functionally equivalent, with Market B's 'confirms an IPO' being covered by Market A's 'official company announcements or credible news sources'. The explicit 'No' conditions in Market A (merger, acquisition, ceases to exist) would implicitly prevent an IPO in Market B, meaning if Market A resolves 'No' for these reasons, Market B would also resolve 'No' because an IPO did not occur.

Catalyst Intel: News reports indicate that the White House is pulling back on vaccine policy, which is 'sidelining' Robert F. Kennedy Jr.'s core 'Make America Healthy Again' movement, according to a close ally. This suggests a significant conflict or diminished influence for RFK Jr. over his primary policy interests within the administration, creating a strong incentive for him to resign from his position as HHS Secretary.

Legal Reasoning: Market B requires Robert F. Kennedy Jr. to leave the specific role of HHS Secretary. Market A is broader, requiring him to leave any role within the Trump Administration. If he leaves as HHS Secretary, he necessarily leaves the Trump Administration. However, he could leave the Trump Administration from a different role (e.g., as an Ambassador or White House staffer), in which case Market A would resolve 'Yes' but Market B would resolve 'No'. The timeframes for both markets are identical ('before 2027' vs. 'by December 31, 2026'). Therefore, Market B's conditions are stricter and a subset of Market A's.

Catalyst Intel: The news presents a mixed and sometimes conflicting picture regarding 2026 GDP growth forecasts across different regions. While S&P Global has revised India's FY26 growth forecast upwards to 7.6%, Goldman Sachs has simultaneously lowered India's 2026 forecast to 5.9%. Additionally, forecasts for countries like Sweden and Australia have been downgraded, often citing geopolitical conflicts. There is no clear, widespread, and unified shift in expectations that would constitute a massive catalyst for overall GDP growth in 2026.

Legal Reasoning: Market A specifies the exact data source and methodology (BEA Advance Estimate for Q4 2026, seasonally adjusted and annualized GDP growth rate for full year 2026) for the condition 'GDP growth in 2026 below 0.0'. Market B uses a more general phrasing 'GDP growth in 2026 below 0.0'. Assuming standard definitions for economic data, Market B implicitly refers to the same official metric specified by Market A. Therefore, the conditions and resolution criteria are virtually identical.